Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 287 is listed as a ribosomal RNA pseudogene. Pseudogenes are defunct genomic sequences derived from functional genes, commonly losing their ability to encode functional products due to mutation or lack of promoter activity[4]. This pseudogene is related to the highly conserved and functionally critical 5S ribosomal RNA gene—a key structural and functional RNA component of the large ribosomal subunit involved in ribosome assembly and protein synthesis[1][3]. However, as a pseudogene (denoted by the "P" in RNA5SP287), it is generally non-functional and lacks coding capacity. There is no evidence that RNA, 5S ribosomal pseudogene 287 is a therapeutic target, biological regulator, or disease biomarker. Assessment of correctness: This target is incorrect as a therapeutic target because: - Pseudogenes (such as RNA, 5S ribosomal pseudogene 287) are typically not expressed as functional RNA molecules and do not have known receptor, enzyme, or transporter activity[4]. - There is no literature or database evidence connecting this specific pseudogene to any disease, biological function, or drug interaction. - The name and aliases are consistent with the conventions for ribosomal pseudogenes catalogued in genomic databases. Context: - 5S ribosomal RNA itself is a functional molecule deeply integrated into ribosome structure and protein synthesis[1][3]. - Some pseudogene transcripts may acquire regulatory roles if expressed, but there is no evidence for regulatory or disease-related function for RNA, 5S ribosomal pseudogene 287 specifically[4]. - If a ribosomal RNA pseudogene is referenced as a target, it almost always reflects an annotation artifact, not a bona fide molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 287 (RNA5SP287).